Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy

Epilepsy and Behavior

Volumn 33, Issue , 2014, Pages 110-114

  Yuen, Alan W C ^a,c   Sander, Josemir W ^a,b,c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

AMPK; Autophagy; Glucose; Intermittent fasting diet; MTOR; Sirtuins

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ANTICONVULSANT ACTIVITY; AUTOPHAGY; CALORIC RESTRICTION; CLINICAL EFFECTIVENESS; DIET THERAPY; EPILEPSY; EPILEPTOGENESIS; EXCITOTOXICITY; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; KETOGENIC DIET; PATIENT SAFETY; REVIEW; SIGNAL TRANSDUCTION;

CALORIC RESTRICTION; EPILEPSY; HUMANS;

EID: 84896356937     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.02.026     Document Type: Review

References (37)

1. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr 1935, 10:63-79.
2. Anderson R.M., Shanmuganayagam D., Weindruch R. Calorie restriction and aging: studies in mice and monkeys. Toxicol Pathol 2009, 37:47-51.
3. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al. Calorie restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
4. Speakman J.R., Mitchell S.E. Calorie restriction. Mol Aspects Med 2011, 32:159-221.
5. Chung K.W., Kim D.H., Park M.H., Choi Y.J., Kim N.D., Lee J., et al. Recent advances in calorie restriction research on aging. Exp Gerontol 2013, 48:1049-1053.
6. Harvie M.N., Pegington M., Mattson M.P., Frystyk J., Dillon B., Evans G., et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) 2011, 35:714-727.
7. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., et al. Intermittent fasting and calorie restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2007, 26:212-220.
8. Mager D.E., Wan R., Brown M., Cheng A., Wareski P., Abernethy D.R., et al. Calorie restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J 2006, 20:631-637.
9. Martin B., Mattson M.P., Maudsley S. Calorie restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev 2006, 5:332-353.
10. Greene A.E., Todorova M.T., McGowan R., Seyfried T.N. Calorie restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
11. Mantis J.G., Centeno N.A., Todorova M.T., McGowan R., Seyfried T.N. Management of multifactorial idiopathic epilepsy in EL mice with calorie restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr Metab (Lond) 2004, 1:11.
12. Eagles D.A., Boyd S.J., Kotak A., Allan F. Calorie restriction of a high-carbohydrate diet elevates the threshold of PTZ-induced seizures to values equal to those seen with a ketogenic diet. Epilepsy Res 2003, 54:41-52.
13. Bough K.J., Schwartzkroin P.A., Rho J.M. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia 2003, 44:752-760.
14. Hartman A.L., Zheng X., Bergbower E., Kennedy M., Hardwick J.M. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia 2010, 51:1395-1402.
15. Kawamura M., Ruskin D.N., Masino S.A. Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J Neurosci 2010, 30:3886-3895.
16. Chung H.Y., Kim H.J., Kim J.W., Yu B.P. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci 2001, 928:327-335.
17. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
18. Devinsky O., Vezzani A., Najjar S., De Lanerolle N.C., Rogawski M.A. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013, 36:174-184.
19. Yuen A.W., Sander J.W. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy. Med Hypotheses 2011, 77:536-540.
20. Han Y., Xie N., Cao L., Zhao X., Liu X., Jiang H., et al. Adenosine monophosphate-activated protein kinase and peroxisome proliferator-activated receptor gamma coactivator 1alpha signaling provides neuroprotection in status epilepticus in rats. Neurosci Lett 2011, 500:133-138.
21. Galanopoulou A.S., Gorter J.A., Cepeda C. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 2012, 53:1119-1130.
22. Ryther R.C., Wong M. Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy. Curr Neurol Neurosci Rep 2012, 12:410-418.
23. Raffo E., Coppola A., Ono T., Briggs S.W., Galanopoulou A.S. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 2011, 43:322-329.
24. McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 2011, 52:e7-e11.
25. Hartman A.L., Santos P., Dolce A., Hardwick J.M. The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice. PLoS One 2012, 7:e45156.
26. Potter W.B., O'Riordan K.J., Barnett D., Osting S.M., Wagoner M., Burger C., et al. Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One 2010, 5:e8996.
27. Weston M.C., Chen H., Swann J.W. Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J Neurosci 2012, 32:11441-11452.
28. McMahon J., Huang X., Yang J., Komatsu M., Yue Z., Qian J., et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis. J Neurosci 2012, 32:15704-15714.
29. Polajnar M., Zerovnik E. Impaired autophagy: a link between neurodegenerative diseases and progressive myoclonus epilepsies. Trends Mol Med 2011, 17:293-300.
30. Contestabile A., Ciani E., Contestabile A. Dietary restriction differentially protects from neurodegeneration in animal models of excitotoxicity. Brain Res 2004, 1002:162-166.
31. Youssef F.F., Ramchandani J., Manswell S., McRae A. Adult-onset calorie restriction attenuates kainic acid excitotoxicity in the rat hippocampal slice. Neurosci Lett 2008, 431:118-122.
32. Duan W., Lee J., Guo Z., Mattson M.P. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci 2001, 16:1-12.
33. Duan W., Guo Z., Mattson M.P. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J Neurochem 2001, 76:619-626.
34. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 2009, 34:1393-1400.
35. Alcain F.J., Villalba J.M. Sirtuin activators. Expert Opin Ther Pat 2009, 19:403-414.
36. Kossoff E.H., Rowley H., Sinha S.R., Vining E.P. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008, 49:316-319.
37. Hartman A.L., Rubenstein J.E., Kossoff E.H. Intermittent fasting: a "new" historical strategy for controlling seizures?. Epilepsy Res 2013, 104:275-279.